Publicaciones (83) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Avian Plasmodium in invasive and native mosquitoes from southern Spain

    Parasites and Vectors, Vol. 17, Núm. 1

  2. Correction to: Avian Plasmodium in invasive and native mosquitoes from southern Spain (Parasites & Vectors, (2024), 17, 1, (40), 10.1186/s13071-024-06133-8)

    Parasites and Vectors

2023

  1. Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice

    PLoS Pathogens, Vol. 19, Núm. 11 November

  2. Bis-6-amidino-benzothiazole Derivative that Cures Experimental Stage 1 African Trypanosomiasis with a Single Dose

    Journal of medicinal chemistry, Vol. 66, Núm. 18, pp. 13043-13057

  3. Dissecting the interstrand crosslink DNA repair system of Trypanosoma cruzi

    DNA Repair, Vol. 125

  4. Endosomal vesicle fusion machinery is involved with the contractile vacuole in Dictyostelium discoideum

    Journal of Cell Science, Vol. 136, Núm. 2

  5. Exposure to Trypanosoma cruzi and Leishmania parasites in dogs from a rural locality of Yucatan, Mexico. A serological survey

    Veterinary Parasitology: Regional Studies and Reports, Vol. 44

  6. First-Row Transition 7-Oxo-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidine Metal Complexes: Antiparasitic Activity and Release Studies

    Pharmaceuticals, Vol. 16, Núm. 10

  7. Identification of Aryl Polyamines Derivatives as Anti-Trypanosoma cruzi Agents Targeting Iron Superoxide Dismutase †

    Pharmaceutics, Vol. 15, Núm. 1

  8. Induction of TLR5, IRAK1, and NF-κB expression by Trichomonas vaginalis in cervical cancer cell (HeLa) and normal human vaginal epithelial cell (HVECs) lines

    Journal of infection in developing countries, Vol. 17, Núm. 8, pp. 1160-1167

  9. Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen

    Frontiers in Tropical Diseases, Vol. 4

  10. The Bioactivity of Xylene, Pyridine, and Pyrazole Aza Macrocycles against Three Representative Leishmania Species †

    Pharmaceutics, Vol. 15, Núm. 3

2022

  1. 5-Nitroindazole derivatives as potential therapeutic alternatives against Acanthamoeba castellanii

    Acta Tropica, Vol. 232

  2. An Updated View of the Trypanosoma cruzi Life Cycle: Intervention Points for an Effective Treatment

    ACS infectious diseases, Vol. 8, Núm. 6, pp. 1107-1115

  3. Biological characteristics of the Trypanosoma cruzi Arequipa strain make it a good model for Chagas disease drug discovery

    Acta Tropica, Vol. 236

  4. Development and evaluation of a real-time PCR for genotyping of Cryptosporidium spp. from water monitoring slides

    Experimental Parasitology, Vol. 242

  5. Validation of a multilocus genotyping scheme for subtyping Cryptosporidium parvum for epidemiological purposes

    Food and Waterborne Parasitology, Vol. 27

2021

  1. Heterocyclic Diamines with Leishmanicidal Activity

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3168-3181

  2. In vitro Leishmanicidal and Trypanosomicidal Properties of Imidazole-Containing Azine and Benzoazine Derivatives

    ChemMedChem, Vol. 16, Núm. 23, pp. 3600-3614

  3. In vitro anti-Acanthamoeba activity of flavonoid glycosides isolated from Delphinium gracile, D. staphisagria, Consolida oliveriana and Aconitum napellus

    Parasitology, Vol. 148, Núm. 11, pp. 1392-1400